Home » UPC decisions » Luxembourg Court of Appeal » CoA Luxembourg, December 17, 2024, Application for suspensive effect, UPC_CoA_810/2024

CoA Luxembourg, December 17, 2024, Application for suspensive effect, UPC_CoA_810/2024

3 min Reading time

Key takeaways

The primary legal issue revolves around the suspensive effect of an appeal, specifically under Rule 223.4 RoP, which allows for suspensive effect in cases of extreme urgency.

The Court emphasized that the applicant must demonstrate the existence of an extreme urgency to justify suspensive effect. In this case, the applicant, the applicant merely argued that it will be be forced to comply with a manifestly wrong order without providing sufficient evidence for an extreme urgency.

Rule 223.4 RoP: Governs applications for suspensive effect in cases of extreme urgency.

Article 74.1 UPCA: States that an appeal shall not have suspensive effect unless decided otherwise by the Court of Appeal.

Rule 220.2 RoP: Pertains to the appeal process.

Article 41(1) UPCA: Relates to the provision of security for legal costs.

Division

Court of Appeal of the Unified Patent Court

UPC number

UPC_CoA_810/2024, App_66516/2024

Type of proceedings

Application for Suspensive Effect

Parties

Applicant and Defendant in the Main Proceedings: Curio Bioscience Inc.

Respondent and Claimant in the Main Proceedings: 10x Genomics, Inc.

Patent(s)

EP 2 697 391 B1

Body of legislation / Rules

Art. 74(1) UPCA

R. 223 RoP


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field